NCT03894410View on ClinicalTrials.gov

Real World Study of Lapatinib Among Metastatic Breast Cancer Patients

CompletedOBSERVATIONAL
Enrollment

242

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

November 15, 2019

Study Completion Date

May 20, 2020

Conditions
Breast Cancer
Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT03894410 - Real World Study of Lapatinib Among Metastatic Breast Cancer Patients | Biotech Hunter | Biotech Hunter